D
Dechert Survey:
Developments in U.S. Securities
Fraud Class Actions Against
Life Sciences Companies
2018 Edition
Dechert survey: Developments in securities fraud class actions against U.S. life sciences companies
|
2
Table of contents
Introduction 3
Life sciences companies remain popular targets for securities fraud litigation 5
– Filing trends 6
– Causes of action 8
2018 class action securities fraud decisions in the life sciences sector 12
– Court decisions regarding alleged misrepre sentations during product development 12
– Court decisions regarding alleged misrepre sentations after pro duct development 12
– Court decisions regarding nancial management 14
Minimizing securities fraud litigation risks 21